ABPWW Company Profile and Key Details

Average 10-day trading volume of 13.99 thousand shares is below the 3-month average of 20.00 thousand, indicating normal recent market interest.

The stock is currently trading near its 52-week low $0.01 and $0.02. With a market capitalization of about $3.40 million, Abpro Holdings Inc is classified as a micro-cap and shows lower-than-market volatility (beta ~-0.00). Key stats such as the average daily volume over the past year has been around 24.52 thousand shares, volume is running light vs its 52-week average. Headquartered in Woburn, MA, Abpro Holdings Inc operates in the Healthcare sector and the Biotechnology industry. Led by CEO Jin Wook Suk, the company employs approximately 6 people and listed since March 09, 2022. Abpro Holdings, Inc., a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and autoimmunity issues.

Abpro Holdings Inc last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.05. This means the shares are trading below this model’s fair value.

Valuation shows Abpro Holdings Inc trading at a premium to the broader market with a P/E of -0.05.

Our AI price prediction model suggests that Abpro Holdings Inc stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Abpro Holdings Inc trades at a P/E ratio of -0.05, slightly below the S&P 500 average, with a price-to-sales ratio of 2.95 and a price-to-book ratio of -0.04 indicating negative book value, which may reflect financial stress. The P/FCF stands at -0.04, also below market averages.